365
Participants
Start Date
June 21, 2018
Primary Completion Date
April 1, 2025
Study Completion Date
April 1, 2025
Dupilumab (SAR231893/REGN668)
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous (sc)"
Asthma controller therapies (incl. prednisone/prednisolone)
"Pharmaceutical form: powder, or solution, or pill~Route of administration: inhaled, oral or parenteral"
Asthma reliever therapies
"Pharmaceutical form: powder or solution~Route of administration: inhaled"
Investigational Site Number : 3480006, Budapest
Investigational Site Number : 3480003, Töröbálint
Investigational Site Number : 3480012, Mezőkövesd
Investigational Site Number : 0360005, North Adelaide
Investigational Site Number : 0320006, Mendoza
Investigational Site Number : 3480002, Gyula
Investigational Site Number : 7100001, Cape Town
Investigational Site Number : 3480008, Szigetvár
Investigational Site Number : 3480001, Székesfehérvár
Investigational Site Number : 3480007, Zalaegerszeg
Columbia University Medical Center- Site Number : 8400013, New York
Northwell Health- Site Number : 8400023, Great Neck
Rochester Regional Health- Site Number : 8400007, Rochester
Immunocarolina LLC Site Number : 8400004, Charlotte
Investigational Site Number : 4840006, Chihuahua City
Investigational Site Number : 4840004, Chihuahua City
Investigational Site Number : 4840003, Durango, Durango
Investigational Site Number : 3800004, Padua
Cincinnati Children's Hospital Medical Center Site Number : 8400008, Cincinnati
Investigational Site Number : 8040004, Dnipro
Investigational Site Number : 8040008, Kryvyi Rig
Investigational Site Number : 3800003, Florence
Investigational Site Number : 8040007, Chernivtsi
Investigational Site Number : 8040005, Kharkiv
Investigational Site Number : 4840001, Monterrey, Nuevo León
Somnos Clinical Research Site Number : 8400022, Lincoln
Investigational Site Number : 8040002, Zaporizhzhya
Investigational Site Number : 8040003, Zaporizhzhya
OK Clinical Research, LLC- Site Number : 8400024, Edmond
Allergy & Asthma Research Center- Site Number : 8400003, San Antonio
Arizona Allergy and Immunology Research- Site Number : 8400002, Gilbert
Asthma and Airway Disease Research Center Site Number : 8400012, Tucson
Peninsula Research Associates Site Number : 8400001, Rolling Hills Estates
Investigational Site Number : 4840002, Veracruz
Investigational Site Number : 6430002, Saint Petersburg
Investigational Site Number : 6430001, Saint Petersburg
Investigational Site Number : 6430003, Saint Petersburg
Investigational Site Number : 6430005, Saint Petersburg
Investigational Site Number : 6430004, Perm
Investigational Site Number : 1700002, Santiago de Cali
Investigational Site Number : 1520007, Viña del Mar
Investigational Site Number : 1520002, Viña del Mar
Investigational Site Number : 1520001, Valdivia
Investigational Site Number : 1520009, Santiago
Division of Pulmonary Medicine and Allergy Medicine- Site Number : 8400006, St Louis
Investigational Site Number : 0320002, CABA
Investigational Site Number : 0320001, CABA
Investigational Site Number : 0320004, Vicente Lopez
Investigational Site Number : 0320003, Buenos Aires
Irmandade da Santa Casa de Misericordia de Porto Alegre- Site Number : 0760001, Porto Alegre
Hospital Sao Lucas da PUCRS- Site Number : 0760007, Porto Alegre
Unidade Ambulatorial de Pesquisa Clinica I - NGP - UNIFESP- Site Number : 0760002, São Paulo
Instituto da Criança of Hospital das Clínicas de São Paulo- Site Number : 0760004, São Paulo
Clinica de Alergia Martti Antila Site Number : 0760006, Sorocaba
Investigational Site Number : 1240003, Québec
Investigational Site Number : 1520005, Santiago
Investigational Site Number : 1700004, Antioquia
Investigational Site Number : 3800005, Roma
Investigational Site Number : 3920013, Chiba
Investigational Site Number : 3920016, Chuo-ku
Investigational Site Number : 3920005, Yotsukaido-shi
Investigational Site Number : 3920015, Fukuoka
Investigational Site Number : 3920011, Fukuoka
Investigational Site Number : 3920008, Shibukawa
Investigational Site Number : 3920014, Onomichi-shi
Investigational Site Number : 3920003, Sapporo
Investigational Site Number : 3920012, Tsu
Investigational Site Number : 3920010, Ureshino-shi
Investigational Site Number : 3920009, Habikino-Shi
Investigational Site Number : 4400005, Šiauliai
Investigational Site Number : 4400003, Utena
Investigational Site Number : 4400001, Vilnius
Investigational Site Number : 4400004, Vilnius
Investigational Site Number : 6160002, Poznan
Investigational Site Number : 6160001, Lodz
Investigational Site Number : 7240001, Barcelona
Investigational Site Number : 7920005, Adana
Investigational Site Number : 7920001, Ankara
Investigational Site Number : 7920003, Istanbul
Investigational Site Number : 7920004, Istanbul
Investigational Site Number : 8040001, Kyiv
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY